The Clinical Core of the Massachusetts ADRC is housed in the Memory Disorders Unit at the Massachusetts General Hospital. The goal of the Clinical Core is to examine, diagnosis and enroll into the ADRC Patient registry men and women from all racial and ethnic backgrounds with AD and related dementias, including frontotemporal dementia, dementia with Lewy bodies, and other parkinsonian syndromes including progressive supranuclear palsy and cortical basoganglionic degeneration, along with individuals with mild cognitive impairment who are at heightened risk to develop AD. Associated goals of the Center are to characterize the neurological, psychiatric and neuropsychological features of dementia in these patient groups and to refer these carefully evaluated patients to specific research projects funded within the ADRC, as well as to national and local research projects. To this historical mission, we have added two new components for genetics and neuroimaging. The Genetic subcore will consolidate separate elements of existing ADRC genetic programs, including the systematic collection of family history on all patients who attend the Clinical Core, genetic counseling, ascertainment of subjects for local and national genetic research projects and DNA banking and genetic analyses. The Neuroimaging subcore will standardize the collection of MR, SPECT and PET images from individuals who attend the Core, refine and apply to these images automated quantitative analytic programs developed at MGH, and facilitate collaboration with MGH investigators and other local and national ADC projects. The Clinical Core supports a wide range of research funded outside of the Clinical Core, including research projects linked to the ADRC (i.e., Project 3) as well as local and national collaborative research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-22
Application #
7063246
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
22
Fiscal Year
2005
Total Cost
$312,490
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Hopp, Sarah C; Lin, Yang; Oakley, Derek et al. (2018) The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease. J Neuroinflammation 15:269
Xiong, Li; van Veluw, Susanne J; Bounemia, Narimene et al. (2018) Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association With Cognition in Cerebral Amyloid Angiopathy. Stroke 49:2330-2336
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Wegmann, Susanne; Eftekharzadeh, Bahareh; Tepper, Katharina et al. (2018) Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J 37:
Racine, Annie M; Brickhouse, Michael; Wolk, David A et al. (2018) The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimers Dement (Amst) 10:301-310
Bennett, Rachel E; Robbins, Ashley B; Hu, Miwei et al. (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289-E1298
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872

Showing the most recent 10 out of 966 publications